HSPA1A and neoplasm: Finally, our pre-clinical data provide a powerful rationale for testing the concurrent inhibition of HSP70 and autophagy in PDAC, and possibly other tumor types where autophagy may serve to protect cancer cells from cytotoxic therapy.